Occidental Asset Management LLC Takes $2.12 Million Position in The Clorox Company $CLX

Occidental Asset Management LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 17,155 shares of the company’s stock, valued at approximately $2,115,000.

Several other hedge funds and other institutional investors have also made changes to their positions in CLX. Nomura Asset Management Co. Ltd. lifted its stake in shares of Clorox by 9.0% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 335,514 shares of the company’s stock worth $40,285,000 after purchasing an additional 27,639 shares during the last quarter. Simplicity Wealth LLC raised its holdings in Clorox by 157.3% in the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,198 shares in the last quarter. Hudson Bay Capital Management LP purchased a new stake in shares of Clorox during the second quarter valued at about $8,568,000. Vise Technologies Inc. purchased a new stake in shares of Clorox during the second quarter valued at about $328,000. Finally, Brookstone Capital Management boosted its holdings in shares of Clorox by 1,395.4% in the 3rd quarter. Brookstone Capital Management now owns 94,332 shares of the company’s stock valued at $11,631,000 after buying an additional 88,024 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 1.2%

Shares of CLX stock opened at $109.95 on Friday. The Clorox Company has a twelve month low of $96.66 and a twelve month high of $164.22. The stock has a market cap of $13.41 billion, a P/E ratio of 17.26, a P/E/G ratio of 0.54 and a beta of 0.58. The stock has a 50 day moving average of $103.13 and a 200 day moving average of $115.26. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a net margin of 11.68% and a return on equity of 358.39%. The business’s revenue was down 18.9% on a year-over-year basis. During the same quarter last year, the company earned $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.5%. Clorox’s dividend payout ratio (DPR) is 77.86%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of analyst reports. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $128.00 to $121.00 and set a “hold” rating on the stock in a research report on Tuesday, November 4th. Wells Fargo & Company lowered their price objective on Clorox from $117.00 to $108.00 and set an “equal weight” rating for the company in a research report on Monday, January 5th. The Goldman Sachs Group decreased their price target on Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a research note on Wednesday, January 7th. Finally, Bank of America decreased their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $122.19.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction that occurred on Friday, November 21st. The stock was bought at an average price of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. This trade represents a 44.44% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is currently owned by corporate insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.